And did we mention, it's free?
Here’s a brief description of the subject matter:
Manufacturers have a legal responsibility to communicate the known risks associated with their medications and ‘duty-to-warn’ responsibilities have traditionally been fulfilled by publishing labeling information online or in reference texts.Why do we care?
However, as physician workflow consolidates around electronic health record systems, manufacturers may increasingly find themselves under scrutiny regarding their ‘duty-to-warn’ efforts – how and where they provide safety messaging will make the difference.
Hear industry experts share the latest developments in:
- ‘Duty-to-warn’ relating to medical malpractice litigation and product liability management, including an update on the Supreme Court’s recent cases and the impact on generics.
- The increasing role of technology in the evolution of ‘duty-to-warn’ benchmarking.
- The growing responsibility on regulatory and marketing operations regarding ‘duty-to-warn’ in healthcare IT systems.
- The importance of labeling information in the physician’s electronic workflow.
Well, Steve McConnell of our blog (the guy who mostly writes the funny Monday posts) is one of the panelists, and he’s going to be presenting much of the legal framework for the webinar. Other panelists include Christopher L. Gaenzle, Assistant General Counsel for litigation at Pfizer; Richard E. Hinson, and former senior marketing executive at Roche; Jay H. Stone, M.D., an interventional cardiologist at the Shore Cardiac Institute in Toms River, N.J. The moderator is Brian McDonough, .M.D., a syndicated medical correspondent.
So if you’d like to interact with Steve, and learn something about the interface between technology and defending litigation involving prescription drugs and medical devices, drop in on this webinar. For additional information, contact Jason Willett at (415) 644-3926 or by email at email@example.com.